Dopamine, striatum, antipsychotics, and questions about weight gain

JAMA Psychiatry

Volumn 73, Issue 2, 2016, Pages 107-108

  Kapur, Shitij ^a   Marques, Tiago Reis ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; DOPAMINE; DOPAMINE 2 RECEPTOR; HISTAMINE H1 RECEPTOR; NEUROLEPTIC AGENT; SEROTONIN 2C RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; SULPIRIDE;

CORPUS STRIATUM; EDITORIAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; REWARD; SCHIZOPHRENIA; VISUAL STIMULATION; WEIGHT GAIN; ANALOGS AND DERIVATIVES; DRUG EFFECTS; FEMALE; MALE; PUTAMEN;

ANTIPSYCHOTIC AGENTS; DOPAMINE D2 RECEPTOR ANTAGONISTS; FEMALE; HUMANS; MALE; PUTAMEN; REWARD; SCHIZOPHRENIA; SULPIRIDE; WEIGHT GAIN;

EID: 84957697862     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2872     Document Type: Editorial

References (7)

1. Musil R, Obermeier M, Russ P, Hamerle M. Weight gain and antipsychotics: A drug safety review. Expert Opin Drug Saf. 2015; 14(1): 73-96.
2. Reist C, Mintz J, Albers LJ, Jamal MM, Szabo S, Ozdemir V. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: An observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol. 2007; 27(1): 46-51.
3. Brandl EJ, Tiwari AK, Zai CC, et al. Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample [published online September 1, 2015]. Pharmacogenomics J. doi: 10.1038/tpj.2015.59.
4. Nielsen MO, Rostrup E,Wulff S, Glenthøj B, Ebdrup BH. Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment [published online January 6, 2016]. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2015.2582.
5. Volkow ND,Wang GJ, Baler RD. Reward, dopamine and the control of food intake: Implications for obesity. Trends Cogn Sci. 2011; 15(1): 37-46.
6. Stice E, Yokum S, Blum K, Bohon C.Weight gain is associated with reduced striatal response to palatable food. J Neurosci. 2010; 30(39): 13105-13109.
7. NirenbergMJ,Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006; 21(4): 524-529.